Pelthos Therapeutics stockholders approve 2026 equity plan, re-elect full board
At its September 29, 2026 annual meeting, Pelthos shareholders elected eight directors, ratified Grant Thornton as auditor, and approved a new equity incentive plan.
Pelthos Therapeutics Inc. held its 2026 Annual Meeting of Stockholders on September 29, 2026, according to an 8-K filed with the SEC. As of the record date of August 4, 2026, the company had 3,828,469 shares of common stock and 52,128 shares of Series A Preferred Stock outstanding1, with each stockholder entitled to one vote per common share, and Series A Preferred voting on an as-converted basis together with common stock as a single class1. A quorum was met, with holders of 3,396,094 votes, representing 70.0% of total voting power as of the record date, present in person or by proxy1.
Stockholders elected all eight director nominees named in the proxy statement to serve until the 2027 annual meeting. Peter Greenleaf received 2,866,344 votes for and 19,577 withheld, with 510,173 broker non-votes1. The other nominees elected were Richard Baxter, Todd Davis, Andrew Einhorn, Ezra Friedberg, Dr. Richard Malamut, Matthew Pauls, and Scott Plesha, each receiving a majority of votes cast.
The vote tally was 3,394,740 for, 1 against, and 1,353 abstentions1.
In addition, stockholders approved the Pelthos Therapeutics Inc. 2026 Equity Incentive Plan, which replaces the company's 2023 Equity Incentive Plan, as amended and restated1. The 2026 Plan became effective immediately upon stockholder approval at the meeting1. A summary of the plan's material terms appears in the company's definitive proxy statement filed with the SEC on August 18, 20261.
Fact check notes
- Imprecise
Pelthos Therapeutics stockholders approve 2026 equity plan, re-elect full board
The filing says the eight nominees were 'elected,' not explicitly stated as a re-election of incumbent directors; 'full board' and 're-elect' are not directly supported but are a reasonable inference. - Checker's noteHeadline's phrase 're-elect full board' implies these were incumbent directors being re-elected, but the 8-K only states the eight nominees were 'elected'—it does not confirm they previously served as directors.
- Sentence removed
Stockholders also ratified the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
copied source wording - Sentence removed
The vote on this proposal was 2,698,543 for, 187,365 against, 13 abstentions, and 510,173 broker non-votes, per the filing.
a figure with no citation
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Where the check questioned a sentence, its note is shown above. Not investment advice.